Tamiflu

153. Public Accounts Committee Report on Tamiflu and Publication of Drug Evaluation Results

A report from the House of Commons Public Accounts Committee concludes that information is routinely withheld from doctors and researchers about the methods and results of clinical trials on treatments currently prescribed in the United Kingdom (1). Invariably the bodies responsible for the approval of new drugs only have access to the results of studies

153. Public Accounts Committee Report on Tamiflu and Publication of Drug Evaluation Results Read More »

122. Disclosure of the Results of Clinical Trials: Case Study of Tamiflu and Implications for Statins

One of the key issues to emerge from the recent spat between Sir Rory Collins and the BMJ about statins (1) has been the refusal of the Cholesterol Treatments Trialists’ Collaboration (CTT) at Oxford University to allow open access to the original clinical trial data. The independent panel set up by the editor of the

122. Disclosure of the Results of Clinical Trials: Case Study of Tamiflu and Implications for Statins Read More »

Scroll to Top